Literature DB >> 23117353

[Operative invasiveness of off-pump coronary artery bypass grafting].

Takanori Suezawa1, Atsushi Aoki, Mitsuhisa Kotani, Mamoru Tago.   

Abstract

OBJECTIVE: In our institution, steroid is administrated intravenously during the anesthesia induction for conventional coronary artery bypass grafting( CABG) to prevent the inflammatory response due to cardiopulmonary bypass and reperfusion injury, however, steroid is not used for off-pump CABG (OPCAB) with expectation of less invasiveness of the procedure. We evaluated the early outcomes and postoperative inflammatory response of conventional CABG with preoperative steroid use and OPCAB.
METHODS: From May 2004 to April 2010, 120 patients underwent elective CABG requiring the ventricle elevation to expose the target vessels. Twenty eight patients(group C)treated with conventional CABG and 92 patients (group O) with OPCAB. Perioperative course was analyzed and compared between the 2 groups.
RESULTS: OPCAB had several advantages such as shorter operative duration, decreased requirement of blood transfusion and myocardial protection compared with conventional CABG. However, frequency of postoperative paroxysmal atrial fibrillation was similar between these techniques and early postoperative C-reactive protein levels were shown to be significantly higher in OPCAB.
CONCLUSIONS: OPCAB has advantage over conventional CABG in blood loss during surgery and myocardial protection. However the inflammatory response was significantly severe in OPCAB. OPCAB might become less invasive with the anti-inflammatory medication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117353

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  1 in total

1.  Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery.

Authors:  Takanori Suezawa; Atsushi Aoki; Mitsuhisa Kotani; Mamoru Tago; Osamu Kobayashi; Akihito Hirasaki; Minako Sano; Nana Kameda; Hiroki Mitsunaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.